89bio, Inc. Interest Expense
89bio, Inc. reported Interest Expense of $1.14 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2025-08-08
- 89bio, Inc. interest expense for the quarter ending 2025-06-30 was $1.14M, a 30.09% increase year-over-year.
- 89bio, Inc. interest expense for the quarter ending 2025-03-31 was $1.27M, a 46.81% increase year-over-year.
- 89bio, Inc. interest expense for the quarter ending 2024-12-31 was $1.19M, a 37.53% increase year-over-year.
- 89bio, Inc. interest expense for the quarter ending 2024-09-30 was $2.36M, a 146.30% increase year-over-year.
- 89bio, Inc. interest expense for fiscal 2024 was $5.29M, a 10.35% increase from fiscal 2023.
- 89bio, Inc. interest expense for fiscal 2023 was $4.79M, a 149.43% increase from fiscal 2022.
- 89bio, Inc. interest expense for fiscal 2022 was $1.92M, a 185.16% increase from fiscal 2021.
- 89bio, Inc. interest expense for fiscal 2021 was $674.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $1.14M 10-Q · filed 2025-08-08 | $2.40M 10-Q · filed 2025-08-08 | $3.60M derived: sum of 3 quarters · filed 2025-08-08 | $5.96M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | $1.27M 10-Q · filed 2025-05-02 | $2.46M derived: sum of 2 quarters · filed 2025-05-02 | $4.82M derived: sum of 3 quarters · filed 2025-05-02 | $5.69M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.55M derived: sum of 2 quarters · filed 2025-02-27 | $4.43M derived: sum of 3 quarters · filed 2025-08-08 | $5.29M 10-K · filed 2025-02-27 |
| 2024-09-30 | $2.36M 10-Q · filed 2024-11-07 | $3.24M derived: sum of 2 quarters · filed 2025-08-08 | $4.10M 10-Q · filed 2024-11-07 | $4.96M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $874.00K 10-Q · filed 2025-08-08 | $1.74M 10-Q · filed 2025-08-08 | $2.60M derived: sum of 3 quarters · filed 2025-08-08 | $3.56M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $863.00K 10-Q · filed 2025-05-02 | $1.73M derived: sum of 2 quarters · filed 2025-05-02 | $2.69M derived: sum of 3 quarters · filed 2025-05-02 | $3.58M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.82M derived: sum of 2 quarters · filed 2025-02-27 | $2.72M derived: sum of 3 quarters · filed 2025-02-27 | $4.79M 10-K · filed 2025-02-27 |
| 2023-09-30 | $959.00K 10-Q · filed 2024-11-07 | $1.85M derived: sum of 2 quarters · filed 2024-11-07 | $3.93M 10-Q · filed 2024-11-07 | $4.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $894.00K 10-Q · filed 2024-08-05 | $2.97M 10-Q · filed 2024-08-05 | $3.51M derived: sum of 3 quarters · filed 2025-02-27 | $4.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.08M 10-Q · filed 2024-05-09 | $2.62M derived: sum of 2 quarters · filed 2025-02-27 | $3.15M derived: sum of 3 quarters · filed 2025-02-27 | $3.59M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.08M derived: sum of 2 quarters · filed 2025-02-27 | $1.51M derived: sum of 3 quarters · filed 2025-02-27 | $1.92M 10-K · filed 2025-02-27 |
| 2022-09-30 | $535.00K 10-Q · filed 2023-11-09 | $969.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.38M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $434.00K 10-Q · filed 2023-08-09 | $842.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $408.00K 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $674.00K 10-K · filed 2024-03-01 |